首页> Bioengineered> A high level of the long non-coding RNA MCF2L-AS1 is associated with poor prognosis in breast cancer and MCF2L-AS1 activates YAP transcriptional activity to enhance breast cancer proliferation and metastasis.

A high level of the long non-coding RNA MCF2L-AS1 is associated with poor prognosis in breast cancer and MCF2L-AS1 activates YAP transcriptional activity to enhance breast cancer proliferation and metastasis.

导出 OA

翻译打印收藏纠错

第一作者： Qing,She

第一单位： Department of Breast Surgery, Baoji Municipal Central Hospital, Baoji, China.

作者： Qing,She ^[1] ; Yuanyuan,Chen ^[1] ; Hong,Liu ^[1] ; Jichao,Tan ^[1] ; Youhuai,Li ^[1]

作者单位： Department of Breast Surgery, Baoji Municipal Central Hospital, Baoji, China. ^[1]

关键词 LncRNA MCF2L-AS1 YAP breast cancer

主题词女(雌)性(Female);人类(Humans);乳腺肿瘤(Breast Neoplasms);细胞系(Cell Line);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);预后(Prognosis);原癌基因蛋白质类(Proto-Oncogene Proteins)

DOI 10.1080/21655979.2022.2074108

PMID 36700469

发布时间 2023-02-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Bioengineered

2022年13卷5期

13437-13451页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A high level of the long non-coding RNA <i>MCF2L-AS1</i> is associated with poor prognosis in breast cancer and <i>MCF2L-AS1</i> activates YAP transcriptional activity to enhance breast cancer proliferation and metastasis.

Bioengineered

相似文献

Bioengineered

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A high level of the long non-coding RNA <i>MCF2L-AS1</i> is associated with poor prognosis in breast cancer and <i>MCF2L-AS1</i> activates YAP transcriptional activity to enhance breast cancer proliferation and metastasis.

Bioengineered

相似文献

Bioengineered

相关期刊

检索历史清除